Most elderly people have a normal bowel habit, but their use of laxatives is increased. Constipation is the main colorectal abnormality, especially in those with mobility problems.
Other important contributory physiological changes in constipation or faecal impaction include deficient colonic propulsion, difficulty defecating, and impaired rectal sensation. A history of chronic constipation, although common in these patients, is not always present. The possibility of other colonic disease should also be considered.
Whole gut transit time does not seem to change with age but has been found to be considerably prolonged (longer than 14 days) in immobile constipated patients. This delay seems to occur mainly in the sigmoid colon and rectum.
Constipation is often associated with "faecal impaction" in elderly people. The term "faecal impaction" has traditionally indicated loading of the rectum with hard faeces. Many elderly patients, however, have massive faecal loading with soft or even liquid faeces and they are more likely to experience faecal soiling. The first step in the management of faecal incontinence is to identify the cause(s) and follow the simple measures described below, which are known to be effective at restoring continence in most cases.
Causes of faecal incontinence
-
Faecal impaction and constipation
When faecal incontinence is due to faecal impaction the initial treatment is to empty the rectum and colon from below by using enemas or suppositories each day until the faecal mass is cleared. Laxatives or stool softeners tend to be unsuccessful because many of these patients have impaction with soft stools. Further softening tends only to increase the frequency of incontinence.
Occasionally, manual removal of faeces is required for patients impacted with very hard faeces. Some patients with severe spinal cord lesions require twice weekly manual evacuations when all other treatments have failed. Dementia-In patients with dementia incontinence is usually secondary to faecal impaction. This should be cleared as described above. If there is a continuing tendency to faecal incontinence or constipation, or both, then a regimen of planned defecation should be implemented by using an enema one to three times a week. To prevent leakage between these enemas a constipating drug may be needed.
Anorectal incontinence-The principles of treatment for anorectal incontinence are similar to those described above. Maintaining a firm stool will help in most cases. Although moderate success has been reported with postanal repair in young and middle aged incontinent patients, its use in elderly patients cannot be recommended as their problems tend to be multifactorial. Gerald Bickler initially worked singlehandedly, but over the next 40 years the practice, in a working class estate, grew into a large multidisciplinary group practice based in a health centre with Gerald as the central figure. He was a member of the local medical committee, secretary of the West Yorkshire branch of the Socialist Health Association, and a founder member, treasurer, and vice chair of the Leeds Doctors' Cooperative-a group of general practitioners who believed that cooperation between principals to provide high quality out of hours care was preferable to using commercial deputising services. Gerald was deeply committed to the NHS and angered by inequality and injustice. The joy he got from his work was always his main motivation, though in the last few years he was pessimistic about the impact on general practice of changes in the NHS.
Myeloma was diagnosed several months before he retired, but he did not change his pattem or hours of work. His retirement was short, but, though he had planned to indulge his love of literature, travel, music, food, walking, and conversation, he never thought that he had retired too late. He is survived by his first wife and their three children (two of whom went into medicine) and by his second wife and stepson. Fritz Deinhardt died while he was still at the height of his powers and directing important medical research. He was a valued chairman of the European Community's programme EVA (European vaccine against AIDS), which supports research on vaccines against AIDS throughout Europe and is run from the National
